The DOI matches its Crossref record.
Apolipoprotein genetic variation and human disease
Abstract
Atherosclerosis is the major public health problem in much of the world today. The information summarized in this review, based on the recognized apolipoprotein structural variants appreciated at both the protein and gene levels, indicates that apolipoprotein genetic variation plays a major role in determining human genetic susceptibility to this disease. With the use of cloned apolipoprotein genes, it should, in the near future, be possible to determine how their expression is regulated; this should provide insight into other classes of mutations of a regulatory nature that might have clinical significance. In addition, the many association and linkage studies currently being undertaken will provide the rationale for cloning defective alleles and determining specific causative mutations. Both structural and regulatory mutations can then be described either with restriction enzymes and Southern blotting or by direct oligonucleotide hybridization techniques in the general population. This will allow the identification of presymptomatic atherosclerosis-susceptible individuals who would be targets for primary preventative therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sladek, F. M., Zhong, W. M., Lai, E., & Darnell, J. E. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2353 · Cited by 1,027
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944
Molecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein
Teng, B., Burant, C. F., & Davidson, N. O. (1993) · Science · doi:10.1126/science.8511591 · Cited by 536
Palm oil: Biochemical, physiological, nutritional, hematological and toxicological aspects: A review
Edem, D. O. (2002) · Plant Foods for Human Nutrition · doi:10.1023/a:1021828132707 · Cited by 428
Structural and functional features of different types of cytoplasmic fatty acid-binding proteins
Veerkamp, J. H., Peeters, R. A., & Maatman, R. G. H. J. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90244-c · Cited by 387
Lipoprotein Metabolism and Renal Failure
Attman, P.-O., Samuelsson, O., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 355
Innerarity, T., Mahley, R., Weisgraber, K., Bersot, T., Krauss, R., Vega, G., Grundy, S., Friedl, W., Davignon, J., & McCarthy, B. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42605-7 · Cited by 352
Ladias, J. A., Hadzopoulou-Cladaras, M., Kardassis, D., Cardot, P., Cheng, J., Zannis, V, & Cladaras, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49613-0 · Cited by 318
The effect of diet on plasma lipids, lipoproteins, and coronary heart disease
Kris-Etherton, P. M., Krummel, D., Russell, M. E., Dreon, D., Mackey, S., Borchers, J., & Wood, P. D. (1988) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)08023-8 · Cited by 303
Dietary fiber and coronary heart disease
Anderson, J. W., Deakins, D. A., Floore, T. L., Smith, B. M., & Whitis, S. E. (1990) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399009527518 · Cited by 268
Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C
Khan, W. A., Blobe, G. C., & Hannun, Y. A. (1995) · Cellular Signalling · doi:10.1016/0898-6568(94)00089-t · Cited by 225
Kaprio, J., Ferrell, R. E., Kottke, B. A., Kamboh, M. I., & Sing, C. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1330 · Cited by 119
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Asialoglycoprotein receptors as important mediators of plasma lipids and atherosclerosis
Igdoura, S. A. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000395 · Cited by 22
Metadata
- Authors
- Breslow, J. L.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 1988-01-01
- Volume
- 68
- Issue
- 1
- Pages
- 85-132
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2280187329
- Cited by
- 168
- References
- 0
- FWCI
- 28.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.